Q2 2019 Getinge AB Earnings Call Transcript
Thank you very much. Good morning and welcome to today's earnings call. I have Lars Sandström, our CFO, with me today who will support me during the call and also present some of the detailed financials. So we can start by moving over to -- right away to Page #2, please. So I'd like to start by summarizing the key takeaways from the second quarter. So we continue to outgrow the markets. We have positive performance in the U.S. continuing. And I was particularly happy to see that our net sales in China increased by more than 30% in the second quarter, so very strong development there. I am pleased with the development in Acute Care Therapies and in Life Science in the quarter, and it's also very good to see that our working capital is continuing to decline despite our growth, and this has a very positive impact on our cash flow as you will see in a short moment.
We do see good progress as well when it comes to many things in our turnaround plan. However, I'm not really satisfied with our gross margins, which were impacted by -- negatively
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |